Okeiro

AI-powered precision medicine for better transplant outcomes

Overview

Okeiro is a French HealthTech startup developing a precision medicine platform to support transplant patients and individuals with chronic diseases. The company applies advanced AI and predictive algorithms to analyze patient data, provide early signals of complications or graft rejection, and personalize treatments for proactive clinical care. By enabling healthcare professionals to detect subtle health trends before critical symptoms arise, Okeiro aims to improve long-term outcomes and quality of life for high-risk patients. The platform is designed in close collaboration with clinical teams and pharmaceutical partners to accelerate validation and adoption within modern healthcare workflows.

History

For founders who won’t stop
short of their vision.